![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-218x150.jpeg "Genetic Link between Alzheimer’s and Brain Inflammation Found")
Newly Identified Prostate Cancer Subtype is Responsive to Immunotherapy
Characterized by the loss of both copies of the CDK12 gene, the subtype occurs in 7% of patients with metastatic castration-resistant cancer
Secondary Findings in Genomic Sequencing Get New Reporting Recommendations
ACMG releases new recommendations for reporting of secondary findings in clinical exome and genome sequencing.
Exosomes from Cancer Cells Could Predict Immunotherapy Responses
University of Pennsylvania researchers contend an immune-evasion mechanism may help explain the differences in responses to immunotherapy
![Whole exome sequencing is becoming more available to patients and will help them distill the sequencing data to candidate genes and link them with therapies. [NCI]](https://www.clinicalomics.com/wp-content/uploads/2019/01/596-218x150.jpeg "Cancer Combination Therapies Tailored to Individuals Show Improved Outcomes")
Cancer Combination Therapies Tailored to Individuals Show Improved Outcomes
Patients with therapy-resistant cancers show improved outcomes if their treatments are personalized according to the molecular profile of their cancer, according to a new...
Research Kits to Identify Breath-Based Biomarkers
Breath Biopsy Kits allow academic, clinical, and pharmaceutical researchers to discover and validate breath-based biomarkers.
DNA MiniPrep Kit
The ZymoBIOMICS™ DNA Mini Kit is designed for purifying DNA from any sample input that is immediately ready for analysis.
Tech Veteran Named CTO of NIH’s All of Us Research Program
Chris Lunt will lead efforts to build an engagement and digital data platform intended to support research based on data from 1M+ Americans.
Genetics of Neurodegenerative Disorders – How Mutations Affect Disease Pathology
Sponsor: Cannon. This webinar highlights current research of the APOE gene, and how its E4 allele affects disease pathology in Alzheimer’s disease.
Seegene Partners with Thermo Fisher Scientific to Enter U.S. Diagnostics Market
Seegene said it will partner Allplex™ assay with Thermo Fisher Scientific’s PCR System, aiming to create a comprehensive MDx solution
![The FDA insists it is not looking to derail ctDNA or stop development of new technologies. [Rutchapong/iStock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/566-218x150.jpeg "Getting Testy Over Liquid Biopsies")
Getting Testy Over Liquid Biopsies
Dazzled by the prospect of a market projected to reach $22 billion,CtDNA tests attract interest from companies, institutions, and regulators
